Skip to content
ChickenStockChickenStock
ResearchBSX
Boston Scientific logo

Boston Scientific (BSX) stock

NYSE

$44.34+0.32%(+0.14)

As of the Nov 13, 2026 close (U.S. Eastern)

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 13, 2026 · Financial period · Trailing twelve months

P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock

P/E

18.35x

P/B

2.51x

P/S

3.05x

Latest earnings

SEC filings

Jul–Sep 2026(FY2026 Q3)

Revenue increased 1.4% from the same period a year earlier.

Key reported figures come first. Select one to see the same quarter across three years.

See the same quarter across three years →

Filed Nov 2, 2026 · 10-Q · SEC EDGAR

Reported results are from SEC EDGAR filings. Reference information only, not investment advice.

Insider transactions

Recent Form 4 filings grouped by person, date and transaction type.

16 SEC filings
  • Mahoney Michael FChairman, President & CEO · Nov 4, 2026Gift252,241 shares · $0
    Avg. price $0
    Show 2 price lots
    • 102,249 shares × $0$0
    • 149,992 shares × $0$0
  • O'Sullivan MiriamSVP, Chief HR Officer · Nov 1, 2026Shares withheld for taxes1,872 shares · $79K
    Avg. price $41.9819,565 shares held after
  • O'Sullivan MiriamSVP, Chief HR Officer · Nov 1, 2026Option exercise3,871 shares · $0
    Avg. price $021,437 shares held after
  • O'Connor Padraig AndrewEVP, Global Operations · Sep 2, 2026Shares withheld for taxes567 shares · $27K
    Avg. price $48.377,892 shares held after
  • O'Connor Padraig AndrewEVP, Global Operations · Sep 2, 2026Option exercise1,171 shares · $0
    Avg. price $08,459 shares held after
  • Morano Susan EDirector · Aug 25, 2026Open-market purchase2,040 shares · $100K
    Avg. price $49.219513,784 shares held after
  • Woodworth EmilySVP, Global Controller and CAO · Aug 11, 2026Other2,930 shares · $150K
    Avg. price $51.192,930 shares held after
  • Monson JonathanEVP and CFO · Aug 10, 2026Other9,908 shares · $500K
    Avg. price $50.469,908 shares held after
  • Habiger David CDirector · Aug 5, 2026Open-market purchase2,100 shares · $100K
    Avg. price $47.58917,160 shares held after
  • Habiger David CDirector · Aug 4, 2026Open-market purchase140 shares · $7K
    Avg. price $48.587915,060 shares held after
  • Mahoney Michael FChairman, President & CEO · Aug 3, 2026Open-market purchase186,240 shares · $9.0M
    Avg. price $48.33231,590,024 shares held after
  • Habiger David CDirector · Aug 3, 2026Open-market purchase1,042 shares · $50K
    Avg. price $48.065514,920 shares held after
  • Mahoney Michael FChairman, President & CEO · Aug 3, 2026Other22,119 shares · $1.1M
    Avg. price $48.4322,119 shares held after
  • LUDWIG EDWARD JDirector · Jul 31, 2026Open-market purchase5,000 shares · $227K
    Avg. price $45.479930,359 shares held after
  • Fitzgerald Joseph MichaelEVP & Group Pres, Cardiology · Jul 31, 2026Other64,198 shares · $3.0M
    Avg. price $46.7364,198 shares held after

Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.

Recent SEC filings

40 filings

Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.

Company overview

Expand ▾

Boston Scientific (BSX) stock information

NYSE

Boston Scientific (BSX) is listed on NYSE. Its market capitalization is about $64.2B. On trailing-twelve-month earnings the P/E ratio is 18.35, and the P/B ratio is 2.51. Return on equity is 13.7%. These figures are computed in-house from official filings and are reference information only.

Boston Scientific — frequently asked questions

What is the P/E ratio of Boston Scientific (BSX)?
On a trailing-twelve-month basis, BSX trades at a P/E ratio of 18.35. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of Boston Scientific?
BSX has a market capitalization of about $64.2B. The figure moves with the share price and is refreshed each trading day.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.